Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA.
J Bone Miner Res. 2012 Nov;27(11):2306-13. doi: 10.1002/jbmr.1697.
Low 25-hydroxyvitamin D (VitD), low sex hormones (SH), and high sex hormone binding globulin (SHBG) levels are common in older men. We tested the hypothesis that combinations of low VitD, low SH, and high SHBG would have a synergistic effect on bone mineral density (BMD), bone loss, and fracture risk in older men. Participants were a random subsample of 1468 men (mean age 74 years) from the Osteoporotic Fractures in Men Study (MrOS) plus 278 MrOS men with incident nonspine fractures studied in a case-cohort design. "Abnormal" was defined as lowest quartile for VitD (<20 ng/mL), bioavailable testosterone (BioT, <163 ng/dL), and bioavailable estradiol (BioE, <11 pg/mL); and highest quartile for SHBG (>59 nM). Overall, 10% had isolated VitD deficiency; 40% had only low SH or high SHBG; 15% had both SH/SHBG and VitD abnormality; and 35% had no abnormality. Compared to men with all normal levels, those with both SH/SHBG and VitD abnormality tended to be older, more obese, and to report less physical activity. Isolated VitD deficiency, and low BioT with or without low VitD, was not significantly related to skeletal measures. The combination of VitD deficiency with low BioE and/or high SHBG was associated with significantly lower baseline BMD and higher annualized rates of hip bone loss than SH abnormalities alone or no abnormality. Compared to men with all normal levels, the multivariate-adjusted hazard ratio (95% confidence interval [CI]) for incident nonspine fracture during 4.6-year median follow-up was 1.2 (0.8-1.8) for low VitD alone; 1.3 (0.9-1.9) for low BioE and/or high SHBG alone; and 1.6 (1.1-2.5) for low BioE/high SHBG plus low VitD. In summary, adverse skeletal effects of low sex steroid levels were more pronounced in older men with low VitD levels. The presence of low VitD in the presence of low BioE/high SHBG may contribute substantially to poor skeletal health.
低 25-羟维生素 D(VitD)、低性激素(SH)和高性激素结合球蛋白(SHBG)水平在老年男性中很常见。我们检验了一个假设,即 VitD、SH 和 SHBG 水平低的组合会对老年男性的骨密度(BMD)、骨丢失和骨折风险产生协同作用。参与者是来自男性骨质疏松性骨折研究(MrOS)的 1468 名男性(平均年龄 74 岁)的随机子样本,加上 278 名 MrOS 男性,他们在病例-队列设计中发生了非脊柱骨折。“异常”定义为 VitD(<20ng/mL)、生物可利用睾酮(BioT,<163ng/dL)和生物可利用雌二醇(BioE,<11pg/mL)最低四分位数;和 SHBG(>59nM)最高四分位数。总体而言,10%的人存在孤立性 VitD 缺乏症;40%的人只有低 SH 或高 SHBG;15%的人同时存在 SH/SHBG 和 VitD 异常;35%的人没有异常。与所有正常水平的男性相比,同时存在 SH/SHBG 和 VitD 异常的男性往往年龄更大、更肥胖,且报告的体力活动较少。孤立性 VitD 缺乏症,以及低 BioT 伴有或不伴有低 VitD,与骨骼测量值无显著相关性。VitD 缺乏症与低 BioE 和/或高 SHBG 相结合与单独的 SH 异常或无异常相比,与较低的基线 BMD 和较高的年度髋骨丢失率显著相关。与所有正常水平的男性相比,在中位随访 4.6 年期间,非脊柱骨折的多变量调整后危险比(95%置信区间[CI])分别为低 VitD 单独的 1.2(0.8-1.8);低 BioE 和/或高 SHBG 单独的 1.3(0.9-1.9);低 BioE/高 SHBG 加上低 VitD 的 1.6(1.1-2.5)。总之,低 VitD 水平对老年男性的骨骼影响更为明显,其性类固醇水平较低。低 BioE/高 SHBG 存在低 VitD 可能会对骨骼健康产生重大影响。